Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene

Journal of Infectious Diseases

Volumn 182, Issue 4, 2000, Pages 1192-1198

  Huang, Laurence ^a   Beard, Charles B ^b   Creasman, Jennifer ^a   Levy, Deborah ^b   Duchin, Jeffrey S ^c,e   Lee, Sherline ^b   Pieniazek, Norman ^b   Carter, Jane L ^b   Del Rio, Carlos ^d   Rimland, David ^d   Navin, Thomas R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DAPSONE; DIHYDROPTEROATE SYNTHASE; SULFANILAMIDE DERIVATIVE; SULFONE;

ADULT; ARTICLE; DNA SEQUENCE; FEMALE; GENE MUTATION; GENOTYPE; GEOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS CARINII PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; UNITED STATES;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANALYSIS OF VARIANCE; ANTIBIOTIC PROPHYLAXIS; DIHYDROPTEROATE SYNTHASE; ETHNIC GROUPS; FEMALE; GENOTYPE; GEOGRAPHY; GEORGIA; HIV INFECTIONS; HUMAN; MALE; MUTATION; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS CARINII; RACIAL STOCKS; SAN FRANCISCO; SULFONAMIDES; SUPPORT, U.S. GOV'T, P.H.S.; WASHINGTON;

PNEUMOCYSTIS CARINII;

EID: 0033800771     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315824     Document Type: Article

References (34)

1. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency
2. An outbreak of community-acquired Pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunction
3. Respiratory illness in persons with human immunodeficiency virus infection: The Pulmonary Complications of HIV Infection Study Group
4. AIDS and the lung
5. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort
6. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997
7. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
8. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus
9. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
10. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era
11. Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia
12. Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia
13. Treatment of experimental pneumocystosis: Review of 7 years of experience and development of a new system for classifying antimicrobial drugs
14. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model
15. Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia
16. Point mutations in the dihydropteroate synthase gene causing sulfonamide resistance
17. Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme
18. Sulfonamide resistance in Streptococcus pyogenes is associated with differences in the amino acid sequence of its chromosomal dihydropteroate synthase
19. Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species
20. Characterization of mutations contributing to sulfathiazole resistance in Escherichia coli
21. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: Dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine
22. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum
23. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria
24. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients
25. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene
26. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia
27. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use
28. Genetic variation in Pneumocystis carinii isolates from different geographic regions: Implications for transmission
29. Dihydropteroate synthase polymorphisms in Pneumocystis carinii
30. Molecular epidemiology of Pneumocystis carinii pneumonia
31. Current issues in the epidemiology, transmission, and reactivation of Pneumocystis carinii
32. Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis
33. Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus